Abstract
Background Psoriasis's effect on diabetes onset is well documented, but its effect on course of diabetes is poorly understood. Objective We sought to compare risks of developing microvascular and macrovascular complications between diabetic patients with and without psoriasis. Methods Adults with 2 or more diabetes diagnoses selected from MarketScan databases (Truven Health Analytics Inc, Ann Arbor, MI) (2000-2006) were classified into 2 cohorts: 2 or more psoriasis diagnoses and without psoriasis diagnosis. Patients with psoriasis were matched using propensity score, and exactly matched using age, sex, and diabetes characteristics with patients without psoriasis. Outcomes were compared between cohorts using Cox regression models. Results In all, 6164 diabetic patients with psoriasis (27% moderate to severe) were matched to 6164 diabetic patients without psoriasis. Patients with psoriasis were significantly more likely to develop microvascular events than patients without psoriasis overall (hazard ratio [HR] 1.14, P <.001) and by psoriasis severity (mild: HR 1.13, P =.004; moderate to severe: HR 1.16, P =.038). Risk of macrovascular events was higher for patients without psoriasis overall (HR 1.13, P =.001) and those with mild psoriasis (HR 1.15, P =.003), but not for moderate to severe cases (HR 1.10, P =.210). Limitations Psoriasis to diabetes association may be underestimated. Conclusion Among diabetic patients, psoriasis is generally associated with higher rates of microvascular and macrovascular complications. Greater psoriasis severity did not increase risk of diabetic complications.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 968-977.e2 |
| Journal | Journal of the American Academy of Dermatology |
| Volume | 72 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1 2015 |
| Externally published | Yes |
Fingerprint
Keywords
- complications
- diabetes
- inflammation
- macrovascular
- microvascular
- observational study
- psoriasis
ASJC Scopus subject areas
- Dermatology
Cite this
Psoriasis and risk of diabetes-associated microvascular and macrovascular complications. / Armstrong, April W.; Guérin, Annie; Sundaram, Murali; Wu, Eric Qiong; Faust, Elizabeth Sara; Ionescu-Ittu, Raluca; Mulani, Parvez.
In: Journal of the American Academy of Dermatology, Vol. 72, No. 6, 01.06.2015, p. 968-977.e2.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Psoriasis and risk of diabetes-associated microvascular and macrovascular complications
AU - Armstrong, April W.
AU - Guérin, Annie
AU - Sundaram, Murali
AU - Wu, Eric Qiong
AU - Faust, Elizabeth Sara
AU - Ionescu-Ittu, Raluca
AU - Mulani, Parvez
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Background Psoriasis's effect on diabetes onset is well documented, but its effect on course of diabetes is poorly understood. Objective We sought to compare risks of developing microvascular and macrovascular complications between diabetic patients with and without psoriasis. Methods Adults with 2 or more diabetes diagnoses selected from MarketScan databases (Truven Health Analytics Inc, Ann Arbor, MI) (2000-2006) were classified into 2 cohorts: 2 or more psoriasis diagnoses and without psoriasis diagnosis. Patients with psoriasis were matched using propensity score, and exactly matched using age, sex, and diabetes characteristics with patients without psoriasis. Outcomes were compared between cohorts using Cox regression models. Results In all, 6164 diabetic patients with psoriasis (27% moderate to severe) were matched to 6164 diabetic patients without psoriasis. Patients with psoriasis were significantly more likely to develop microvascular events than patients without psoriasis overall (hazard ratio [HR] 1.14, P <.001) and by psoriasis severity (mild: HR 1.13, P =.004; moderate to severe: HR 1.16, P =.038). Risk of macrovascular events was higher for patients without psoriasis overall (HR 1.13, P =.001) and those with mild psoriasis (HR 1.15, P =.003), but not for moderate to severe cases (HR 1.10, P =.210). Limitations Psoriasis to diabetes association may be underestimated. Conclusion Among diabetic patients, psoriasis is generally associated with higher rates of microvascular and macrovascular complications. Greater psoriasis severity did not increase risk of diabetic complications.
AB - Background Psoriasis's effect on diabetes onset is well documented, but its effect on course of diabetes is poorly understood. Objective We sought to compare risks of developing microvascular and macrovascular complications between diabetic patients with and without psoriasis. Methods Adults with 2 or more diabetes diagnoses selected from MarketScan databases (Truven Health Analytics Inc, Ann Arbor, MI) (2000-2006) were classified into 2 cohorts: 2 or more psoriasis diagnoses and without psoriasis diagnosis. Patients with psoriasis were matched using propensity score, and exactly matched using age, sex, and diabetes characteristics with patients without psoriasis. Outcomes were compared between cohorts using Cox regression models. Results In all, 6164 diabetic patients with psoriasis (27% moderate to severe) were matched to 6164 diabetic patients without psoriasis. Patients with psoriasis were significantly more likely to develop microvascular events than patients without psoriasis overall (hazard ratio [HR] 1.14, P <.001) and by psoriasis severity (mild: HR 1.13, P =.004; moderate to severe: HR 1.16, P =.038). Risk of macrovascular events was higher for patients without psoriasis overall (HR 1.13, P =.001) and those with mild psoriasis (HR 1.15, P =.003), but not for moderate to severe cases (HR 1.10, P =.210). Limitations Psoriasis to diabetes association may be underestimated. Conclusion Among diabetic patients, psoriasis is generally associated with higher rates of microvascular and macrovascular complications. Greater psoriasis severity did not increase risk of diabetic complications.
KW - complications
KW - diabetes
KW - inflammation
KW - macrovascular
KW - microvascular
KW - observational study
KW - psoriasis
UR - http://www.scopus.com/inward/record.url?scp=84929654045&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929654045&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2015.02.1095
DO - 10.1016/j.jaad.2015.02.1095
M3 - Article
VL - 72
SP - 968-977.e2
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
SN - 0190-9622
IS - 6
ER -